Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.

Area of Science:

• Neuroscience
• Cell Biology
• Molecular Biology

Background:

• Alpha-synuclein (SNCA) aggregation is central to synucleinopathies (e.g., Parkinson disease).
• The autophagy-lysosomal pathway (ALP) degrades SNCA and influences its aggregation.
• Extracellular SNCA's role in pathology suggests prion-like propagation, but its secretion mechanisms and microenvironmental impact are unclear.

Purpose of the Study:

• To investigate the molecular interplay between intracellular pathways, SNCA aggregation, secretion, and microenvironmental response.
• To determine the primary source of SNCA-induced toxicity in synucleinopathies.

Main Methods:

• Utilized a cell culture model of SNCA aggregation.
• Employed SNCA transgenic mice.
• Inhibited the autophagy-lysosomal pathway (ALP) using bafilomycinA1.

Main Results:

• ALP inhibition reduced intracellular SNCA aggregation but increased secretion of smaller, more toxic oligomers.
• Secreted SNCA species exacerbated microenvironmental responses, including uptake, inflammation, and cellular damage.
• Low-aggregated SNCA was released via exosomes and RAB11A pathways; high-aggregated SNCA was secreted through membrane shedding.

Conclusions:

• The ALP links intracellular protein degradation to nonclassical secretion of toxic SNCA species.
• Impaired ALP in disease enhances SNCA secretion, leading to detrimental microenvironmental responses.
• Extracellular SNCA species are the primary drivers of toxicity in synucleinopathies, suggesting intracellular aggregation may be protective.